Ardea Biosciences (RDEA) Presents Preclinical Data on Lead MEK Inhibitor, RDEA119, at ACG 2008
Tweet Send to a Friend
Ardea Biosciences, Inc. (Nasdaq: RDEA) announced today that a poster entitled "RDEA119, a Potent and Highly Selective MEK1/2 Inhibitor is ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
